The list above may contain links to third party web sites. These are provided solely as a convenience to you and not as an endorsement by EMD Serono, Inc. of the content on such third-party web sites. EMD Serono, Inc. is not responsible for the content of linked third-party sites and does not make any representations regarding the content or accuracy of materials on such third-party sites. If you decide to access linked third-party sites, you do so at your own risk.
Growth hormone therapy should not be initiated in patients with acute critical illness due to complications following open heart or abdominal surgery, multiple accidental trauma or acute respiratory failure. Zorbtive® is contraindicated in patients with active neoplasia (either newly diagnosed or recurrent). Any anti-tumor therapy should be completed prior to starting therapy with Zorbtive®. Zorbtive® is contraindicated in patients with a known hypersensitivity to growth hormone. Zorbtive® can cause serious side effects including allergic reactions, acute pancreatitis, diabetes or blood sugar problems, high blood pressure in the brain (intracranial hypertension), muscle or joint pain, swelling or stiffness, and carpal tunnel syndrome. Zorbtive® may also cause nausea, vomiting, stomach pain/gas and reactions at the injection site.
If this time frame does not satisfy any specific urgency you may have with your request, please contact us at 1-888-275-7376
Please expect our call within 15 minutes of your specified time.
CLOSE